Content about BOTHELL

January 7, 2011
Pfizer forms licensing agreement with Seattle Genetics

Pfizer has paid Seattle Genetics $8 million to license its antibody technology, Seattle Genetics said Thursday.

September 29, 2010
Teva, OncoGenex commence phase-3 trial for advanced prostate cancer drug

Teva Pharmaceutical Industries and OncoGenex Pharmaceuticals have started a late-stage clinical trial of an investigative...

September 13, 2010
Seattle Genetics, Genmab to develop cancer therapeutics

Biotech companies Seattle Genetics and Genmab will collaborate to develop antibody treatments for cancer, the...

© 2013 Drug Store News. All Rights Reserved.